Comparison of analytical methods in the determination of two venlafaxine fatalities

Journal of Analytical Toxicology

Volumn 21, Issue 2, 1997, Pages 166-169

  Long, Christopher ^a   Crifasi, Joseph ^a   Maginn, Diane ^a   Graham, Michael ^a   Teas, Shaku ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Urology Associates of DuPage   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VENLAFAXINE;

ADULT; ARTICLE; CAPILLARY GAS CHROMATOGRAPHY; CASE REPORT; FATALITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTOXICATION; MALE; TOXIN ANALYSIS;

EID: 0030946339     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/21.2.166     Document Type: Article

References (14)

1. E.A. Muth, J.T. Haskins, J.A. Moyer, G.E. Husbands, S.T. Nielsen, and E.B. Siggs. Antidepressant biochemical profile of the novel bicyclic compound WY-45,030, an ethyl cyclohexanol derivative. Biochem. Pharmacol. 35: 4493-97 (1986).
2. J.T. Haskins, J.A. Moyer, E.A. Muth, and E.B. Sigg. DMI, WY-45,030, WY-45-881 and ciramadol inhibit locus coeruleus neuronal activity. Eur. J. Pharmacol. 115: 139-46 (1985).
3. Venlafaxine-A new antidepressant. Medical Letter on Drugs and Therapeutics 36(924): 49-50 (1994).
4. Effexor (venlafaxine hydrochloride) Tablets. Wyeth Laboratories, Inc., product insert, December 29, 1993.
5. K.J. Klamerus. Introduction of a composite parameter to the pharmacokinetics of venlafaxine and its active O-desmethyl metabolite. J. Clin. Pharm. 32(8): 716-24 (1992).
6. R.C. Baselt and R.H. Cravey. Disposition of Toxic Drugs and Chemicals in Man. 3rd ed. Year Book Medical Publishers, Chicago, IL, 1989, pp 125-28.
7. B. Levine, A.J. Jenkins, R. Jufer, and J.E. Smialek. Distribution of venlafaxine in two postmortem cases. Presented at SOFT, Baltimore, MD, October 1995.
8. A.T. Parsons, R.M. Anthony, and J.E. Meeker. Two fatal cases of venlafaxine poisoning. J. Anal. Toxicol. 20: 266-68 (1996).
9. D. Manca, L. Ferron, and J. Weber. A system for toxicological screening by capillary chromatography with use of a drug retention index based on nitrogen-containing reference compounds. Clin. Chem. 35(4): 601-607 (1989).
10. New Drugs, Venlafaxine. Toxi-News 13(2): 10-11 (1994).
11. D.R. Hicks, D. Wolaniuk, A. Russell, N. Cavanaugh, and M. Krami. A high performance liquid chromatographic method for the simultaneous determination of venlafaxine and Odesmethylvenlafaxine in biological fluids. Ther. Drug Monit. 16(1): 100-107 (1994).
12. R.C. Baselt. Analytical Procedures for Therapeutic Drug Monitoring and Emergency Toxicology. 2nd ed. PSG Publishing, Littleton, MA, 1987, pp 13-14.
13. Data on File, Wyeth-Ayerst Laboratories, protocol 600A-125.
14. A. Fantaskey and K.K. Burkhart. A case report of venlafaxine toxicity. Clin. Toxicol. 33(4): 359-61 (1995).